checkAd
    Startseite > Aktien > Neurogene > Nachrichten
    Neurogene Aktie
    36,36
     
    USD
    +2,74 %
    +0,97 USD
    Letzter Kurs 15:52:17 Nasdaq
    35,68
     
    USD
    100 STK
    Geldkurs 15:54:16
    37,00
     
    USD
    100 STK
    Briefkurs 15:54:16
    ISIN: US64135M1053 · WKN: A3EX79 · SYM: NGNE · USA

    Neueste Nachrichten

    Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
    22.04.24 · Business Wire (engl.) · Neurogene
    Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
    18.03.24 · Business Wire (engl.) · Neurogene
    Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
    04.03.24 · Business Wire (engl.) · Neurogene
    Neurogene to Participate in Upcoming Investor Conferences
    29.02.24 · Business Wire (engl.) · Neurogene
    Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
    16.01.24 · Business Wire (engl.) · Neurogene
    Neurogene Announces Business Update and 2024 Outlook
    05.01.24 · Business Wire (engl.) · Neurogene
    Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
    19.12.23 · Business Wire (engl.) · Neurogene
    Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
    22.09.23 · globenewswire · Neurogene
    NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX
    25.07.23 · Business Wire (engl.) · Neurogene
    NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders
    18.07.23 · Business Wire (engl.) · Neurogene
    Neurogene and Neoleukin Announce Definitive Merger Agreement
    18.07.23 · globenewswire · Neurogene
    Neoleukin: NBC feiert +108% – Schicht im Schacht?
    05.05.23 · Sharedeals · Neurogene